H. Lee Moffitt Cancer Center & Research Institute

MAY/JUNE 2001

Vol 8, No 3 CME Pretest

In this issue, the topic of sarcomas is addressed. First, answer the pretest questions below. After reading the articles, proceed with answering the CME posttest questions.

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• recognize the classic radiographic appearances of sarcomas,

• appreciate the value of fine-needle aspiration in their diagnosis,

• discuss selected molecular abnormalities and be familiar with gastrointestinal stromal tumors,

• know the special issues regarding the management of ex tremity and foot sarcomas, and

• recognize hyperthermia isolated limb perfusion as a therapeutic option for extremity sarcomas.

This program was planned in accordance with ACCME Essentials.

Release Date: May 1, 2001
Expiration Date: May 1, 2002


Pretest

1. A periosteal reaction around a tumor in bone that is described as having a “ground glass” appearance is most characteristic of:

a. fibrous dysplasia
b. osteosarcoma
c. intramedullary infarct
d. chondroid lesion

2. In the experience of Ward et al, fine-needle aspiration biopsy can provide histogenetic subtyping of bone sarcomas in what proportion of cases?

a. 36%
b. 61%
c. 82%
d. 100%

3. What is the most common primary site for a gastrointestinal stromal tumor?

a. small intestine
b. stomach
c. rectum
d. colon

 




© Copyright 1996 - 2012 H. Lee Moffitt Cancer Center & Research Institute